Showing results (11-20 of 84) with videos related to
Sort By:
Pageof 9
Clinical Oral Investigations|April 27, 2016
Does Botulinum neurotoxin type A treatment for sialorrhea change oral health?Janne Tiigimäe-Saar, Pille Taba, Tiia TammeNeurotoxicology|November 4, 2019
Cognitive profile of patients with manganese-methcathinone encephalopathyMargus Ennok, Katrin Sikk, Sulev Haldre, et al.Behavioural Neurology|November 21, 2015
Functional Performance and Associations between Performance Tests and Neurological Assessment Differ in Men and Women with Parkinson's DiseaseKadri Medijainen, Mati Pääsuke, Aet Lukmann, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|December 2, 2019
Subacute administration of both methcathinone and manganese causes basal ganglia damage in mice resembling that in methcathinone abusersAndres Asser, Atsuko Hikima, Mari Raki, et al.Health and Quality of Life Outcomes|March 28, 2008
Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39)Ulle Krikmann, Pille Taba, Taavi Lai, et al.Neurorehabilitation|July 1, 2019
Versatile guideline-based physiotherapy intervention in groups to improve gait speed in Parkinson's disease patientsKadri Medijainen, Mati Pääsuke, Aet Lukmann, et al.Neurorehabilitation|November 15, 2021
Structured guideline-based physiotherapy reduces difficulties in activities of daily living in Parkinson's diseaseKadri Medijainen, Mati Pääsuke, Aet Lukmann, et al.Parkinson'S Disease|March 16, 2011
Manganese-Induced Parkinsonism due to Ephedrone AbuseKatrin Sikk, Sulev Haldre, Sten-Magnus Aquilonius, et al.Brain and Behavior|October 28, 2017
Factors associated with motor complications in Parkinson's diseaseLiis Kadastik-Eerme, Nele Taba, Toomas Asser, et al.Neuroepidemiology|April 17, 2019
Incidence and Mortality of Parkinson's Disease in EstoniaLiis Kadastik-Eerme, Nele Taba, Toomas Asser, et al.Pageof 9